Posted on July 31st, 2009 by Health News
Sanofi-aventis U.S. announced that the U.S. Food and Drug Administration (FDA) approved Sculptra(R)Aesthetic (injectable poly-L-lactic acid) for the correction of shallow to deep nasolabial fold (smile lines) contour deficiencies and other facial wrinkles which are treated with the appropriate injection technique in healthy patients. Sculptra(R)Aesthetic works gradually to offer natural-looking results that can last up [...]
No Comments »
Filed under: Pharmacy News
Posted on July 31st, 2009 by Health News
The US-based PATH Malaria Vaccine Initiative (MVI), the United States Agency for International Development (USAID) Malaria Vaccine Development Program (MVDP), and Dutch biopharmaceutical company Crucell N.V. today announced a collaboration to accelerate development of a promising type of malaria vaccine.
No Comments »
Filed under: Pharmacy News
Posted on July 31st, 2009 by Health News
During a meeting in Atlanta on Wednesday, a “federal advisory committee issued sweeping guidelines … for a vaccination campaign against the pandemic swine flu strain, identifying more than half the U.S. population as targets for the first round of vaccinations,” CNN reports (Hellerman, 7/29).
No Comments »
Filed under: Pharmacy News
Posted on July 31st, 2009 by Health News
The U.S. Food and Drug Administration has approved Colcrys to treat acute flairs in patients with gout, a recurrent and painful form of arthritis, and patients with familial Mediterranean fever (FMF), an inherited inflammatory disorder. The medication’s active ingredient is colchicine, a complex compound derived from the dried seeds of a plant known as the [...]
No Comments »
Filed under: Pharmacy News
Posted on July 31st, 2009 by Health News
Covance has announced it has entered into a definitive agreement with Merck & Co., Inc. relating to the supply of genomic analysis services.
No Comments »
Filed under: Pharmacy News
Posted on July 31st, 2009 by Health News
The Council of the Royal Pharmaceutical Society of Great Britain has announced a fee increase of 2.2% for 2010, following the outcome of the 2010 fees consultation and a review of the Society’s financial position. It is the second year in a row that fees have not [...]
No Comments »
Filed under: Pharmacy News
Posted on July 31st, 2009 by Health News
The Royal Pharmaceutical Society has called for clarification of the responsible pharmacist requirements but will not be asking the Department of Health to amend the commencement date of the regulations. The Society’s Council debated the responsible pharmacist requirements in the light of concerns amongst community and hospital pharmacists about their implementation.
No Comments »
Filed under: Pharmacy News
Posted on July 31st, 2009 by Health News
The Royal Pharmaceutical Society welcomed the decision by the Medicines and Healthcare Products Regulatory Agency that medicines containing ephedrine and pseudoephedrine should retain their status as pharmacy (P) medicines. President Steve Churton said: “We are delighted at the MHRA’s decision to keep cold and flu remedies containing ephedrine and pseudoephedrine as pharmacy (P) [...]
No Comments »
Filed under: Pharmacy News
Posted on July 31st, 2009 by Health News
The NPA is pleased by today’s decision from the MHRA to keep pseudoephedrine a P medicine and have no doubt that community pharmacies will continue to ensure pseudoephedrine is sold in line with MHRA guidance. John Turk, NPA Chief Executive said: “We are absolutely delighted that our members were able to take up [...]
No Comments »
Filed under: Pharmacy News
Posted on July 31st, 2009 by Health News
The National Prescribing Service (NPS) warns people are playing Russian roulette with their health when they take medicines inappropriately. Media reports this week about people mixing sleeping tablet, zolpidem (Stilnox), with energy drink Red Bull™ have failed to highlight the risks people are taking when they intentionally misuse pharmaceuticals. NPS [...]
No Comments »
Filed under: Pharmacy News
